Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Orin M. Goldblum's publication output changed over time?
ScholarIQpublication output · 2009–2021
Output grew100% over the shown period — from 1 works in 2009 to 2 in 2021.
1
1
1
1
1
2
2
2
20092010201120122015201620182021
What are the most-cited papers on Orin M. Goldblum?
ScholarIQmost cited works
Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis
Alan Menter, Kenneth B. Gordon, Craig L. Leonardi, Yihua Gu, Orin M. Goldblum
S58727509. 2010162 Citations
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)
Eric L. Simpson, Seth Forman, Jonathan I. Silverberg, Matthew Zirwas, Emanual Maverakis, George Han, Emma Guttman‐Yassky, Daniel Marnell, Robert Bissonnette, Jill Waibel, Fabio P. Nunes, Amy M. DeLozier, Robinette Angle, Margaret Gamalo, Katrin Holzwarth, Orin M. Goldblum, Jinglin Zhong, Jonathan Janes, Kim Papp
S58727509. 2021136 Citations
Factors affecting sleep quality in patients with psoriasis
Smitha Gowda, Orin M. Goldblum, W. Vaughn McCall, Steven R. Feldman
S58727509. 2009110 Citations
Ixekizumab treatment improves fingernail psoriasis in patients with moderate‐to‐severe psoriasis: results from the randomized, controlled and open‐label phases of <scp>UNCOVER</scp>‐3
P.C.M. van de Kerkhof, Lyn Guenther, A.B. Gottlieb, Michael Sebastian, Jashin J. Wu, Peter Foley, Akimichi Morita, Orin M. Goldblum, L. Zhang, J. Erickson, Susan Ball, Phoebe Rich
Journal of the European Academy of Dermatology and Venereology. 201682 Citations
Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis
Richard G. Langley, Phoebe Rich, Alan Menter, Gerald G. Krueger, Orin M. Goldblum, Yves Dutronc, Baojin Zhu, Hong Wei, Gregory S. Cameron, Michael Heffernan
Journal of the European Academy of Dermatology and Venereology. 201581 Citations
Related on ScholarIQ
Eli Lilly (United States)
Institution
Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis
Paper
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)
Paper
Factors affecting sleep quality in patients with psoriasis
Paper
Ixekizumab treatment improves fingernail psoriasis in patients with moderate‐to‐severe psoriasis: results from the randomized, controlled and open‐label phases of <scp>UNCOVER</scp>‐3
Paper
Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis
Paper